BioCentury
ARTICLE | Company News

Vanda hires Kelly as CFO

November 13, 2010 1:03 AM UTC

Neurology company Vanda Pharmaceuticals (NASDAQ:VNDA) hired James Kelly as SVP and CFO, effective Dec. 13. Kelly was previously VP, controller of MedImmune LLC, a subsidiary of AstraZeneca plc (LSE:AZ...